Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.
DiNubile MJ, Chow JW, Satishchandran V, Polis A, Motyl MR, Abramson MA, Teppler H. DiNubile MJ, et al. Among authors: satishchandran v. Antimicrob Agents Chemother. 2005 Aug;49(8):3217-21. doi: 10.1128/AAC.49.8.3217-3221.2005. Antimicrob Agents Chemother. 2005. PMID: 16048928 Free PMC article. Clinical Trial.
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).
Paterson DL, Rossi F, Baquero F, Hsueh PR, Woods GL, Satishchandran V, Snyder TA, Harvey CM, Teppler H, Dinubile MJ, Chow JW. Paterson DL, et al. Among authors: satishchandran v. J Antimicrob Chemother. 2005 Jun;55(6):965-73. doi: 10.1093/jac/dki117. Epub 2005 Apr 22. J Antimicrob Chemother. 2005. PMID: 15849262
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, Malafaia O, Fernandez A, Choe KA, Carides A, Satishchandran V, Teppler H; Protocol 017 Study Group. Solomkin JS, et al. Among authors: satishchandran v. Ann Surg. 2003 Feb;237(2):235-45. doi: 10.1097/01.SLA.0000048551.32606.73. Ann Surg. 2003. PMID: 12560782 Free PMC article. Clinical Trial.
In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).
Chow JW, Satishchandran V, Snyder TA, Harvey CM, Friedland IR, Dinubile MJ. Chow JW, et al. Among authors: satishchandran v. Surg Infect (Larchmt). 2005 Winter;6(4):439-48. doi: 10.1089/sur.2005.6.439. Surg Infect (Larchmt). 2005. PMID: 16433608
In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, Satishchandran V, McCarroll K, DiNubile MJ, Chow JW. Rossi F, et al. Among authors: satishchandran v. J Antimicrob Chemother. 2006 Jul;58(1):205-10. doi: 10.1093/jac/dkl199. Epub 2006 May 22. J Antimicrob Chemother. 2006. PMID: 16717055
In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
Bochicchio GV, Baquero F, Hsueh PR, Paterson DL, Rossi F, Snyder TA, McCarroll K, Satishchandran V, Dinubile MJ, Chow JW. Bochicchio GV, et al. Among authors: satishchandran v. Surg Infect (Larchmt). 2006 Dec;7(6):537-45. doi: 10.1089/sur.2006.7.537. Surg Infect (Larchmt). 2006. PMID: 17233571
20 results